Towards Healthcare
Precision Oncology Market Share, Companies and Growth by 2032

Precision Oncology Market Size (USD 258.35 Bn) Report by 2032

The report covers Precision Oncology Market Companies and Analysis such as Thermo Fisher Scientific, Inc., Invitae Corporation, Illumina, Inc., Myriad Genetics, Inc., AstraZeneca, Rain Oncology Inc., and many others segmented into diagnostics and therapeutics by product type. Cancer types addresses breast cancer, colorectal cancer, lung cancer, blood cancer, prostate cancer and others. The key end-users are pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories and healthcare data companies. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Precision Oncology Market Assessment

  • Overview
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies
  • Global Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa

North America Precision Oncology Market Assessment

  • Overview
  • North America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • North America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • North America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Europe Precision Oncology Market Assessment

  • Overview
  • Europe Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Europe Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Europe Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Asia-Pacific Precision Oncology Market Assessment

  • Overview
  • Asia-Pacific Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Asia-Pacific Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Asia-Pacific Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Latin America Precision Oncology Market Assessment

  • Overview
  • Latin America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Latin America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Latin America Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Middle East and Africa Precision Oncology Market Assessment

  • Overview
  • Middle East and Africa Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Diagnostics
    • Therapeutics
  • Middle East and Africa Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by Cancer Type (2021 – 2033)
    • Breast cancer
    • Colorectal cancer
    • Lung cancer
    • Blood Cancer
    • Prostate Cancer
    • Others
  • Middle East and Africa Precision Oncology Market Size Value (US$) and Volume (Billion Tons), by End-Use (2021 – 2033)
    • Pharmaceutical & Biotechnology Companies 
    • Hospitals & Diagnostic Laboratories
    • Healthcare Data Companies

Company Profiles

  • Thermo Fisher Scientific, Inc. 
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Invitae Corporation
  • Illumina, Inc.
  • Myriad Genetics, Inc
  • AstraZeneca
  • Rain Oncology Inc.
  • Strata Oncology, Inc.
  • Repare Therapeutics
  • Relay Therapeutics
  • Exscientia
  • Exact Sciences Corporation

Conclusion & Recommendations

  • Insight Code: 5054
  • No. of Pages: 150
  • Format: PDF/PPT/Excel
  • Published: June 2023
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

The field of precision oncology is rapidly advancing, with ongoing research and clinical trials focused on identifying new genetic alterations and developing targeted therapies. As our understanding of cancer genetics continues to grow, precision oncology is expected to play a significant role in shaping the future of cancer treatment.

Some challenges of precision oncology include the high cost of genetic testing, the need for comprehensive tumor profiling, limited availability of targeted therapies for certain genetic alterations, and the complexity of interpreting genomic data and translating it into effective treatment strategies.

Precision oncology offers the potential for personalized treatment options that are tailored to the genetic makeup of a patients tumor. This can lead to improved treatment outcomes, reduced side effects, and better overall patient care.

American Cancer Society Inc, National Library of Medicine, and World Health Organization

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509